Pathway for patients with suspected Breast Cancer Median Wait (days) Pathway for patients with suspected Breast Cancer 2ww referral received in secondary care 11 Days First Seen Triple assessment – One Stop – Breast Clinic 11 Relevant verbal and written information provided Is cancer confirmed or still suspected? Clinical examination imaging +/- biopsies No Results discussed with patient Provide ongoing psychological support & assessment Yes Allocate Breast Care Nurse / Key Worker Holistic and rehabilitation assessment. Proposed treatment plan/further treatment outlined Discharge or follow up as per protocol 16-18 years old – refer to Paediatric Oncology (GNCC) for treatment and TYA MDT for discussion 19-24 years old – continue on tumour site specific pathway & refer to TYA MDT for discussion. Further diagnostics See TYA pathway No Yes Inform patient’s GP of serious diagnosis Arrange further biopsies/imaging Initial MDT discussion of investigation results, treatment & rehabilitation plan plus consideration for clinical trials Histology/scan results available See Breast Rehabilitation Care Pathway liaise & involve healthcare professional as required Further investigations carried out 20 Days *Inter Provider Transfer Network Best Practice Further diagnostics Yes 31 13 Days No Decision to Treat 44 Agreed proposed treatment plan, follow up or discharge with patient 15 Days Chemotherapy Surgery Radiotherapy Endocrine therapy Bisphosphonates Biological agents First Treatment Primary endocrine therapy Primary chemotherapy Surgery +/- reconstruction Supportive palliative care 59 Patient assessed MDT discussion to review histology & staging results also consider for clinical trials Further investigations required? Yes Further investigations as required No Earliest Clinically Appropriate Date (ECAD) for commencement of subsequent treatment Chemotherapy Is adjuvant treatment required? Endocrine Therapy Yes Radiotherapy No Appropriate after care Biological Agent * Less than 1% of breast patients receive treatment at different Trusts Breast Cancer Ideal Pathway [final]